Researchers find potential target to prevent CRC spread

09/14/2011 | Genetic Engineering & Biotechnology News

Vanderbilt University researchers said a protein called blood vessel epicardial substance may be a potential drug target for preventing the spread of colorectal cancer. They reported in the Journal of Clinical Investigation that BVES is downgraded in colorectal cancer, which leads to cancer spread, but that reintroducing it can stop cells from beginning the metastasis process.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Sr. Compliance Director Ethics and Compliance
Medtronic
Fridley, MN
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC